Marketing Manager

Gary M. Marowsky, CPA / MBA

** ******** *****

Hillsborough, NJ 08844

H: 908-***-**** ********@*******.*** C: 908-***-****

EXECUTIVE FINANCE DIRECTOR

Extensive, diverse experience in business advocacy/financial partnership,

internal control, system integrity and compliance, including U.S /

International business, working in both US and foreign currencies.

Financial expertise in external reporting, management reporting, planning

and analysis, and acquisitions and divestitures. Additional key strengths

include:

Operations Marketing/Research Systems

Scorecard Implementation Product Revenue JDE Installation

Optimization

Shared Services Marketing Services WW Planning Installation

Optimization (Adaytum)

Profitability Analysis Clinical Trial Hyperion / Cognos Systems

Optimization

Board / Management Pricing Policy Analysis Global & Local

Presentations Acquisition Repositories

SEC/External Reporting Analysis/Negotiation Clinical Portfolio

Optimization Tool

Major Accomplishments

. Developed and implemented a new monthly and quarterly financial reporting

book for the Board of Directors, focusing on geographic and franchise

segmentation.

. Installed a new Worldwide Planning and Reporting System for collection of

actual, current year estimates and next year plan's, which enabled a 40%

reduction in the collection and consolidation time and a 50% reduction

of IT support costs.

. Developed and implemented a new Operational/Financial Scorecard to enable

the CEO and the Board of Directors to monitor critical performance linked

to the compensation system.

. Reduced Worldwide Marketing Services costs by approximately $100M in the

areas of storage, procurement, marketing symposia and market research

projects.

. Established a new finance product support group and analysis for the

Chief Marketing Officer, as the company moved from a region based

organization to a matrix franchise/region structure. This enabled newly

appointed General Managers to oversee products from end-to-end

(development to patent expiry).

. Developed and implemented new financial analyses contributing

approximately $8B in sales ($.5B above plan) by optimizing the use of

resources from product and country perspectives.

. Completed external SEC financial information for the $7B purchase of

Medco, a pharmacy benefits management company. Collaborated with internal

and external attorneys to conduct the due diligence required to complete

the acquisition.

. Implemented a Shared Services group for the company's Procure-to-Pay

function by consolidating all domestic locations, Canada and Puerto Rico,

and outsourcing document management and microfilming. Actions led to a

40% reduction in staff.

. Developed and implemented a four day finance training course for new and

existing employees, which encompassed the finance function, career

opportunities, policies and procedures and enabling systems. Course

enabled employees to understand their roles in the control environment

under Sarbanes-Oxley.

Professional Experience

Merck & Co., Inc

Controller Bone, Respiratory, Immunology and Endocrine (2007 - 2008)

Identified opportunities to increase sales and operating income of Merck's

largest product lines ($8B in sales) by optimizing investments across the

product portfolio and regions. Installed a Hyperion/Essbase planning and

reporting system to enable efficient operating and monitoring of results

from a historical and prospective basis. Collaborated extensively with the

Research Clinical Trials area to prioritize/optimize trials in order to

maximize revenues for product launches and in-line products. Approved

pricing policy changes for new and in-line products balancing revenue and

volume effects. Reported to the General Manager over the product portfolio.

gary M. Marowsky, CPA / MBA

H: 908-***-**** ********@*******.*** Page 2

Merck & Co., Inc (continued)

Controller Worldwide Human Health Marketing (2004 - 2007)

Supported the Chief Marketing Officer and senior staff with financial

controls, reporting, analysis and forecasting. Reviewed and approved

significant investments for the Marketing Services and Franchise Support

organizations supporting all international sites. Implemented new reporting

systems and led a project, which enabled reductions in marketing services

support costs of over $100M worldwide. Built a global staff of 21 finance

professionals responsible for reporting total results of Merck's worldwide

products which, was reviewed with the President Global Human Health and

CEO. Supported the Clinical Development area and developed new and novel

analyses to prioritize trials across Merck's portfolio. Finance

representative on the Senior Executive Human Health Committee (included

Presidents of Marketing and Research) where I presented financial results

and analyses to Senior Research and Marketing Management, to facilitate

resource allocation/portfolio optimization.

Executive Director Global Finance Information Services (2002 - 2004)

Responsible for the Finance area's global information technology, domestic

Procure-to-Pay (Purchasing through Payment) and Finance training groups,

including over 100 employees. Installed several new systems, including a

worldwide planning and reporting system via Adaytum, JDE installations in

several international sites, and implementation of global and local

repositories.

. Reduced headcount by 40% through outsourcing several manual processes to

external companies both within the US and off-shore.

. Initiated the transformation of the P-t-P group to a shared service

center by consolidating functions, previously performed at other domestic

locations as well as Canada and Puerto Rico.

. Created a Finance 101 course for both new and existing employees which

enhanced the implementation of Sarbanes-Oxley.

Executive Director Corporate Planning and Reporting (1993 - 2002)

Responsible for the financial planning and reporting of Merck & Company's

worldwide operations. Supported the CFO and CEO with planning, reporting

and analysis, and the impact of strategic investment candidates.

. Implemented a new planning and reporting system, via Hyperion and

subsequently Essbase which vastly improved the turnaround time for

information to Merck's CFO/CEO, Management Committee and Board of

Directors.

. Created an on-line Executive Information System, which enabled senior

executives to access critical financial information on a timely basis to

help monitor the business.

. Developed a new scorecard for evaluation of the company's results by

Senior Management and the Board of Directors, which was linked to

employee annual compensation.

. Completed the due diligence and SEC reporting needs for the $7B

acquisition of Medco, a pharmacy benefits management company.

. Created and implemented new Worldwide Human Health franchise reporting

and analysis to enable product investment optimization.

Senior Director of Accounting (1990 - 1993)

Responsible for the entire accounting function. Previous positions included

Director and Manager positions in Consolidation Accounting, General

Accounting, Property Accounting, Royalty Accounting, Cost Accounting, Tax

Accounting and other areas within the Corporate Accounting function.

EDUCATION

MBA Finance (Economics and International Business), Rider University,

Lawrenceville, NJ

BS Accounting (honors), Montclair State University, Montclair,

NJ

CERTIFICATION

Certified Public Accountant (CPA), State of New Jersey

Contact this candidate